Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.

MLA

Dodick, David W., et al. “Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association, vol. 319, no. 19, May 2018, pp. 1999–2008. EBSCOhost, https://doi.org/10.1001/jama.2018.4853.

APA

Dodick, D. W., Silberstein, S. D., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2018). Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 319(19), 1999–2008. https://doi.org/10.1001/jama.2018.4853

Chicago

Dodick, David W., Stephen D. Silberstein, Marcelo E. Bigal, Paul P. Yeung, Peter J. Goadsby, Tricia Blankenbiller, Melissa Grozinski-Wolff, Ronghua Yang, Yuju Ma, and Ernesto Aycardi. 2018. “Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.” JAMA: Journal of the American Medical Association 319 (19): 1999–2008. doi:10.1001/jama.2018.4853.